Diploma (LON:DPLM) Issues Earnings Results

Diploma (LON:DPLM) announced its quarterly earnings results on Monday. The company reported GBX 64.30 ($0.84) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of GBX 63.40 ($0.83) by GBX 0.90 ($0.01), Digital Look Earnings reports.

Shares of Diploma stock opened at GBX 1,753 ($22.91) on Wednesday. The stock’s fifty day moving average is GBX 1,657.60 and its 200-day moving average is GBX 1,563.12. The firm has a market capitalization of $1.99 billion and a PE ratio of 34.37. Diploma has a 12-month low of GBX 1,144 ($14.95) and a 12-month high of GBX 1,954 ($25.53).

The business also recently announced a dividend, which will be paid on Wednesday, January 22nd. Stockholders of record on Thursday, November 28th will be given a dividend of GBX 20.50 ($0.27) per share. The ex-dividend date of this dividend is Thursday, November 28th. This is a positive change from Diploma’s previous dividend of $8.50. This represents a dividend yield of 1.15%. Diploma’s payout ratio is 0.51%.

A number of equities research analysts have recently issued reports on the company. Royal Bank of Canada boosted their target price on Diploma from GBX 1,280 ($16.73) to GBX 1,400 ($18.29) and gave the stock a “sector performer” rating in a research report on Thursday, August 22nd. Peel Hunt reaffirmed a “hold” rating on shares of Diploma in a research report on Monday. Barclays boosted their target price on Diploma from GBX 1,420 ($18.55) to GBX 1,500 ($19.60) and gave the stock an “equal weight” rating in a research report on Tuesday. Finally, JPMorgan Chase & Co. lowered Diploma to a “neutral” rating and cut their target price for the stock from GBX 1,760 ($23.00) to GBX 1,730 ($22.61) in a research report on Tuesday. Seven equities research analysts have rated the stock with a hold rating, The company currently has an average rating of “Hold” and a consensus target price of GBX 1,490 ($19.47).

Diploma Company Profile

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in North America, Europe, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies consumables and instruments for the diagnostic testing of blood, tissue, and other samples in hospital pathology and life sciences laboratories; electrosurgery and minimally invasive surgery equipment and consumables for use in hospital operating rooms; and surgical medical devices, and related consumables and services to GI endoscopy suites in hospitals and private clinics.

Recommended Story: 12b-1 Fees

Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.